Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
vBMA Clot for Spinal Fusion Surgery
NCT05947175Active, not recruiting
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- May 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised trial in Degenerative spine disease (2 arms), sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Brantigan classification at 12 months. Started May 2023; status: active, not recruiting.
02
Conditions
Degenerative spine disease
Beyond the preview
Go deeper on NCT05947175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05947175.